HomeFENC • NASDAQ
add
Fennec Pharmaceuticals Inc
Previous close
$8.12
Day range
$7.93 - $8.34
Year range
$3.96 - $8.56
Market cap
223.71M USD
Avg Volume
81.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 8.75M | -65.52% |
Operating expense | 9.19M | -17.12% |
Net income | -1.16M | -109.08% |
Net profit margin | -13.31 | -126.31% |
Earnings per share | -0.06 | -110.01% |
EBITDA | -782.00K | -105.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.68M | -55.70% |
Total assets | 46.40M | -32.94% |
Total liabilities | 52.28M | -21.00% |
Total equity | -5.88M | — |
Shares outstanding | 27.62M | — |
Price to book | -38.67 | — |
Return on assets | -4.42% | — |
Return on capital | -15.00% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.16M | -109.08% |
Cash from operations | -4.32M | -111.06% |
Cash from investing | — | — |
Cash from financing | 359.00K | 131.71% |
Net change in cash | -3.96M | -110.44% |
Free cash flow | -1.40M | -116.02% |
About
Founded
1996
Headquarters
Website
Employees
32
